News Website

Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer - Physician's Weekly

Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer Physician's Weekly

Published: Dec. 31, 2024, 12:27 p.m.

Read Full Article

Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer - Frontiers

Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer Frontiers

Published: Dec. 30, 2024, 11:50 p.m.

Read Full Article

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - BioMed Central

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery BioMed Central

Published: Dec. 30, 2024, 4:33 a.m.

Read Full Article

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - bmcwomenshealth.biomedcentral.com

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery bmcwomenshealth.biomedcentral.com

Published: Dec. 30, 2024, 4:33 a.m.

Read Full Article

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.

Read Full Article

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma - Nature.com

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma Nature.com

Published: Dec. 28, 2024, 3:08 a.m.

Read Full Article

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports Nature.com

Published: Dec. 28, 2024, 2:37 a.m.

Read Full Article

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer Nature.com

Published: Dec. 28, 2024, 2:37 a.m.

Read Full Article

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway Journal of Translational Medicine

Published: Dec. 27, 2024, 1:02 p.m.

Read Full Article

Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels - Frontiers

Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels Frontiers

Published: Dec. 26, 2024, 4:01 p.m.

Read Full Article

Latest Articles

Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer - Physician's Weekly

Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer - Frontiers

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - BioMed Central

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - bmcwomenshealth.biomedcentral.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer - Nature.com

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels - Frontiers

Subscribe to Our Newsletter